Ohnuma, Hiroyuki <br/><br/>
Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study.  [electronic resource] 

 -  Cancer science  Nov 2018 
 - 3554-3563 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>1349-7006 
<br/><br/><label>Standard No.: </label>10.1111/cas.13772  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carcinoma, Squamous Cell--drug therapy<br/>Docetaxel<br/>Drug Administration Schedule<br/>Esophageal Neoplasms--drug therapy<br/>Esophageal Squamous Cell Carcinoma<br/>Esophagectomy<br/>Feasibility Studies<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Japan<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Organoplatinum Compounds--administration & dosage<br/>Survival Analysis<br/>Taxoids--administration & dosage<br/>Treatment Outcome